$LGND
LIGAND PHARMACEUTICALS INC

2023 Q3 Form 10-Q Financial Statement

#000088616323000050 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $32.87M $26.37M $57.42M
YoY Change -50.27% -54.08% -32.19%
Cost Of Revenue $3.490M $1.669M $12.36M
YoY Change -75.34% -86.5% -59.6%
Gross Profit $29.38M $24.70M $45.06M
YoY Change -43.43% -45.19% -16.69%
Gross Profit Margin 89.39% 93.67% 78.47%
Selling, General & Admin $14.66M $11.29M $14.59M
YoY Change -15.96% -22.61% -0.86%
% of Gross Profit 49.9% 45.7% 32.37%
Research & Development $5.532M $6.854M $19.12M
YoY Change -74.9% -64.15% 19.84%
% of Gross Profit 18.83% 27.75% 42.43%
Depreciation & Amortization $8.600M $9.495M $13.27M
YoY Change -36.19% -28.43% 5.46%
% of Gross Profit 29.27% 38.45% 29.44%
Operating Expenses $5.532M $6.854M $45.53M
YoY Change -74.9% -84.95% 185.38%
Operating Profit $3.078M -$1.983M -$469.0K
YoY Change 383.96% 322.81% -101.03%
Interest Expense $1.000K $284.0K -$2.049M
YoY Change -99.7% -113.86% -141.96%
% of Operating Profit 0.03%
Other Income/Expense, Net -$15.22M $5.154M $82.00K
YoY Change -6987.78% 6185.37% -100.66%
Pretax Income -$12.14M $3.171M -$636.0K
YoY Change -1517.04% -598.58% -101.91%
Income Tax -$1.871M $881.0K $259.0K
% Of Pretax Income 27.78%
Net Earnings -$10.27M $2.290M -$895.0K
YoY Change -2642.82% -355.87% -102.91%
Net Earnings / Revenue -31.26% 8.69% -1.56%
Basic Earnings Per Share -$0.59 $0.13 -$0.05
Diluted Earnings Per Share -$0.59 $0.13 -$53.06K
COMMON SHARES
Basic Shares Outstanding 17.36M shares 17.27M shares 16.86M shares
Diluted Shares Outstanding 17.38M shares 17.73M shares 17.06M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $190.5M $219.0M $147.9M
YoY Change 56.91% 48.07% -50.99%
Cash & Equivalents $19.28M $28.45M $5.280M
Short-Term Investments $171.2M $190.6M $142.7M
Other Short-Term Assets $2.097M $2.770M $7.804M
YoY Change -80.49% -64.51% 24.47%
Inventory $25.39M $26.91M $24.77M
Prepaid Expenses
Receivables $36.00M $27.99M $62.31M
Other Receivables $0.00 $0.00 $964.0K
Total Short-Term Assets $254.0M $276.7M $243.8M
YoY Change 15.23% 13.51% -40.67%
LONG-TERM ASSETS
Property, Plant & Equipment $16.18M $11.38M $70.70M
YoY Change -51.59% -83.9% 301.05%
Goodwill $103.8M $105.7M
YoY Change -42.73%
Intangibles $314.8M $325.4M
YoY Change -39.1%
Long-Term Investments $13.99M
YoY Change
Other Assets $8.426M $4.495M $41.97M
YoY Change 34.19% -89.29% 1384.09%
Total Long-Term Assets $515.2M $481.4M $832.5M
YoY Change -37.94% -42.18% -1.52%
TOTAL ASSETS
Total Short-Term Assets $254.0M $276.7M $243.8M
Total Long-Term Assets $515.2M $481.4M $832.5M
Total Assets $769.2M $758.1M $1.076B
YoY Change -26.78% -29.56% -14.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.475M $9.582M $19.15M
YoY Change -84.42% -49.97% 10.88%
Accrued Expenses $10.64M $7.291M $17.05M
YoY Change -45.0% -57.24% 68.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $115.0M
YoY Change -100.0% -100.0% 255508.89%
Total Short-Term Liabilities $15.73M $29.39M $167.9M
YoY Change -88.37% -82.49% 219.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $43.67M $21.66M $63.40M
YoY Change 98.96% -65.83% 126.38%
Total Long-Term Liabilities $43.67M $21.66M $63.40M
YoY Change 98.96% -65.83% 126.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.73M $29.39M $167.9M
Total Long-Term Liabilities $43.67M $21.66M $63.40M
Total Liabilities $101.3M $93.21M $273.9M
YoY Change -56.75% -65.97% -41.69%
SHAREHOLDERS EQUITY
Retained Earnings $484.8M $495.1M
YoY Change 3.52%
Common Stock $18.00K $17.00K
YoY Change 5.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $667.9M $664.9M $802.4M
YoY Change
Total Liabilities & Shareholders Equity $769.2M $758.1M $1.076B
YoY Change -26.78% -29.56% -14.33%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$10.27M $2.290M -$895.0K
YoY Change -2642.82% -355.87% -102.91%
Depreciation, Depletion And Amortization $8.600M $9.495M $13.27M
YoY Change -36.19% -28.43% 5.46%
Cash From Operating Activities $7.600M -$82.00K $11.88M
YoY Change -62.91% -100.69% -41.58%
INVESTING ACTIVITIES
Capital Expenditures $10.90M $203.0K -$6.588M
YoY Change -351.79% -103.08% 37.42%
Acquisitions
YoY Change
Other Investing Activities -$8.600M $7.759M $44.44M
YoY Change -136.59% -82.54% 84.04%
Cash From Investing Activities -$19.50M $7.556M $37.85M
YoY Change -201.69% -80.04% 95.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.200M -67.76M -59.44M
YoY Change -107.84% 13.99% 19.03%
NET CHANGE
Cash From Operating Activities 7.600M -82.00K 11.88M
Cash From Investing Activities -19.50M 7.556M 37.85M
Cash From Financing Activities 3.200M -67.76M -59.44M
Net Change In Cash -8.700M -60.28M -9.713M
YoY Change 647.42% 520.64% -5.29%
FREE CASH FLOW
Cash From Operating Activities $7.600M -$82.00K $11.88M
Capital Expenditures $10.90M $203.0K -$6.588M
Free Cash Flow -$3.300M -$285.0K $18.47M
YoY Change -113.3% -101.54% -26.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4495000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4736000 usd
CY2023Q2 us-gaap Assets
Assets
758105000 usd
CY2022Q4 us-gaap Assets
Assets
762668000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9582000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5307000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7291000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15681000 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
11387000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
680000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
670000 usd
CY2023Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
76695000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
448000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
457000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
29388000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
98810000 usd
CY2023Q2 lgnd Liability For Contingent Value Rights
LiabilityForContingentValueRights
3505000 usd
CY2022Q4 lgnd Liability For Contingent Value Rights
LiabilityForContingentValueRights
3456000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
27665000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
30615000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10991000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10336000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21664000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21966000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
93213000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
165183000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17352000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17352000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16951000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16951000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
17000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
17000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
170741000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
147590000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-967000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-984000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
495101000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
450862000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
664892000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
597485000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
758105000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
762668000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26366000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50126000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70345000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86642000 usd
CY2023Q2 us-gaap Cost Direct Material
CostDirectMaterial
1669000 usd
CY2022Q2 us-gaap Cost Direct Material
CostDirectMaterial
12361000 usd
us-gaap Cost Direct Material
CostDirectMaterial
5386000 usd
us-gaap Cost Direct Material
CostDirectMaterial
17060000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
8539000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
8550000 usd
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
17078000 usd
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
17130000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6854000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8467000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22142000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24011000 usd
CY2023Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
28349000 usd
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
41464000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
58123000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
75847000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1983000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
8662000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
12222000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
10795000 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
3991000 usd
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-1909000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
43524000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-14786000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2320000 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
298000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
3755000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
432000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
284000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
438000 usd
us-gaap Interest Expense
InterestExpense
524000 usd
us-gaap Interest Expense
InterestExpense
1227000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-873000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2048000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-270000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4303000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5154000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
46485000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11278000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3171000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8661000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
58707000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-483000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
881000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3938000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12803000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-153000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2290000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
12599000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
45904000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-330000 usd
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 usd
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-13494000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1665000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-15950000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2290000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-895000 usd
us-gaap Net Income Loss
NetIncomeLoss
44239000 usd
us-gaap Net Income Loss
NetIncomeLoss
-16280000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.13
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.75
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.67
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.02
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.80
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.10
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.95
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17276000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16868000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17170000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16846000 shares
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.13
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.74
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.57
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.02
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.79
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.09
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17730000 shares
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-32000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-35000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
17000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-149000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-930000 usd
CY2023Q1 lgnd Adjustments To Additional Paid In Capital Increase Due To Separation
AdjustmentsToAdditionalPaidInCapitalIncreaseDueToSeparation
1665000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
44256000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16429000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
597485000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-762000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5931000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
49000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9110000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7207000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-32000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2290000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
664892000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
821159000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-114000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
604000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9499000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-35000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-895000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
802365000 usd
lgnd Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
-108000 usd
lgnd Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
1266000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18994000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26921000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
659000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-44000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
501000 usd
lgnd Amortization Of Commercial License And Other Economic Rights
AmortizationOfCommercialLicenseAndOtherEconomicRights
-814000 usd
lgnd Amortization Of Commercial License And Other Economic Rights
AmortizationOfCommercialLicenseAndOtherEconomicRights
-190000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
13138000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
18543000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1246000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
12925000 usd
lgnd Gain Loss On Short Term Investments
GainLossOnShortTermInvestments
43524000 usd
lgnd Gain Loss On Short Term Investments
GainLossOnShortTermInvestments
-14786000 usd
lgnd Finance Lease And Operating Lease Right Of Use Asset Amortization
FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization
897000 usd
lgnd Finance Lease And Operating Lease Right Of Use Asset Amortization
FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization
3054000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
153000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-67000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2476000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-23208000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10966000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9740000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4960000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4357000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
16001000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
9011000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
130000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
3508000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33866000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
63889000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
88989000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
38472000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
88832000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
177554000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
20666000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
24830000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
750000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2617000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11463000 usd
lgnd Proceeds From Commercial License Rights
ProceedsFromCommercialLicenseRights
213000 usd
lgnd Proceeds From Commercial License Rights
ProceedsFromCommercialLicenseRights
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-33000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18105000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
151732000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
76854000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
223303000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12535000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1011000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4187000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5922000 usd
lgnd Payments To Contingent Value Right Holders Financing Activity
PaymentsToContingentValueRightHoldersFinancingActivity
0 usd
lgnd Payments To Contingent Value Right Holders Financing Activity
PaymentsToContingentValueRightHoldersFinancingActivity
1416000 usd
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0 usd
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
206000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-26000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-27000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-68532000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-229863000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16561000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14242000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45006000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19522000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28445000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5280000 usd
us-gaap Interest Paid Net
InterestPaidNet
288000 usd
us-gaap Interest Paid Net
InterestPaidNet
1038000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
20000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
532000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3800000 usd
lgnd Accrued Inventory Purchases
AccruedInventoryPurchases
2646000 usd
lgnd Accrued Inventory Purchases
AccruedInventoryPurchases
9161000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
17000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-149000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div>
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26366000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50126000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70345000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86642000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
158508000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
288000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4340000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
154456000 usd
CY2023Q2 lgnd Debt Securities Available For Sale And Equity Securities Fvni
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
190596000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
108778000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
415000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5451000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
103742000 usd
CY2022Q4 lgnd Debt Securities Available For Sale And Equity Securities Fvni
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
166864000 usd
CY2023Q2 lgnd Equity Securities Fvni Share Sold In Period
EquitySecuritiesFVNIShareSoldInPeriod
1300000 shares
CY2023Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
16600000 usd
lgnd Equity Securities Fvni Share Sold In Period
EquitySecuritiesFVNIShareSoldInPeriod
4500000 shares
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
37200000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
89245000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
89187000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
5846000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
5816000 usd
CY2023Q2 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
95091000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
95003000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
65 position
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
100000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2023Q2 lgnd Covid19 Accounts Receivable Allowance For Credit Loss Period Increase Decrease
COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
-90000.00 usd
lgnd Covid19 Accounts Receivable Allowance For Credit Loss Period Increase Decrease
COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
50000.00 usd
CY2022Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023Q2 us-gaap Goodwill
Goodwill
105673000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
105673000 usd
CY2023Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
431050000 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
448128000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2343000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6201000 usd
CY2023Q2 lgnd Accrued Subcontractor Expenses Current
AccruedSubcontractorExpensesCurrent
1756000 usd
CY2022Q4 lgnd Accrued Subcontractor Expenses Current
AccruedSubcontractorExpensesCurrent
1756000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
807000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
662000 usd
CY2023Q2 lgnd Accrued Customer Deposits Current
AccruedCustomerDepositsCurrent
621000 usd
CY2022Q4 lgnd Accrued Customer Deposits Current
AccruedCustomerDepositsCurrent
621000 usd
CY2023Q2 lgnd Accrued Supplier Expenses Current
AccruedSupplierExpensesCurrent
268000 usd
CY2022Q4 lgnd Accrued Supplier Expenses Current
AccruedSupplierExpensesCurrent
634000 usd
CY2023Q2 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
180000 usd
CY2022Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
12000 usd
CY2023Q2 lgnd Licensee Accrual Current
LicenseeAccrualCurrent
45000 usd
CY2022Q4 lgnd Licensee Accrual Current
LicenseeAccrualCurrent
3989000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1271000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1806000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7291000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15681000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
7207000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
7001000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
13138000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
14110000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.039
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.030
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.041
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.030
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.494
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.526
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.500
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M18D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M18D
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17276000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16868000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17170000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16846000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17730000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17058000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17851000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16846000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4862000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6794000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6400000 shares
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 position
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1700000 usd
CY2010Q1 lgnd Number Of Contingent Value Rights Series
NumberOfContingentValueRightsSeries
4 contingent_value_right
CY2022Q2 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2023Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2023Q2 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2021 lgnd Payments To Unwind Warrants
PaymentsToUnwindWarrants
18400000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.278
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.455
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.218
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.317
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1800000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
63.57
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
CY2023Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
50000000 usd
lgnd Lessee Increase Decrease In Operating Lease Assets Due To Modification
LesseeIncreaseDecreaseInOperatingLeaseAssetsDueToModification
1100000 usd
lgnd Lessee Increase Decrease In Operating Lease Liabilities Due To Modification
LesseeIncreaseDecreaseInOperatingLeaseLiabilitiesDueToModification
1100000 usd
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000886163-23-000050-index-headers.html Edgar Link pending
0000886163-23-000050-index.html Edgar Link pending
0000886163-23-000050.txt Edgar Link pending
0000886163-23-000050-xbrl.zip Edgar Link pending
a101_ligand-directorcompen.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lgnd-20230630.htm Edgar Link pending
lgnd-20230630.xsd Edgar Link pending
lgnd-20230630_g1.jpg Edgar Link pending
lgnd_63023exhibit311.htm Edgar Link pending
lgnd_63023exhibit312.htm Edgar Link pending
lgnd_63023exhibit321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
lgnd-20230630_def.xml Edgar Link unprocessable
lgnd-20230630_lab.xml Edgar Link unprocessable
lgnd-20230630_pre.xml Edgar Link unprocessable
lgnd-20230630_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lgnd-20230630_cal.xml Edgar Link unprocessable